October 31st, 2008 A Britain stem cell clinical trial has raised hope for those heart patients. The study finds that a heart patient could dramatically improve survival and quality of life, if the stem cell from his own heart can be delivered into his heart.

May 7th, 2007 Australia's adult stem cell company, Mesoblast Limited has announced that the United States Food and Drug Administration (US FDA) has cleared the Investigational New Drug Submission (IND) of its US-based sister company, Angioblast Systems Inc., to commence a Phase 2 clinical trial of its allogeneic, or 'off-the-shelf', adult stem cells for patients with heart attacks. The Phase 2 clinical trial will be based at the Texas Heart Institute, and will follow a similar protocol to the one used by the same investigators in preclinical studies for the IND submission.

April 26th, 2008 Mr Robin Marston, a 61-year-old bus driver from West Drayton in London, has taken part in a new clinical trial, a pioneering stem-cell program at The Barts and The London Heart Attack Center. In the first clinical trial of its kind, Doctors took stem cells from bone marrow in lower back of the patient.

May 10th, 2007 Australia's adult stem cell company, Mesoblast Limited has announced that the United States Food and Drug Administration (US FDA) has cleared the Investigational New Drug Submission (IND) of its US-based sister company, Angioblast Systems Inc., to commence a Phase 2 clinical trial of its allogeneic, or 'off-the-shelf', adult stem cells for patients with heart attacks. The Phase 2 clinical trial will be based at the Texas Heart Institute, and will follow a similar protocol to the one used by the same investigators in preclinical studies for the IND submission.

November 6th, 2005 Osiris Therapeutics, Inc. announced today that its multi-center, human clinical stem cell trial for the treatment of patients suffering from heart attacks has successfully passed the first safety milestone of the trial.

May 23rd, 2009 Researchers from Netherlands have claimed that Injecting bone marrow stem cells into the heart's muscular wall could restore blood flow to hearts with blocked arteries. Dutch researcher Jan van Ramshorst of Leiden University Medical Center and colleagues have shown in a small trial that stem cell injection can helped blood flow, reduced pain and even helped patients to exercise adequately.

June 15th, 2009 This human trial is designed to evaluate the safety and efficacy of  Cardio3 BioSciences second generation stem cell therapy in patients with heart failure. The first patient was treated in March 2009.

October 2nd, 2008 Report shows that any major surgery done on any parts of the body puts great stress on the body's organs, none more so than the kidneys, and half of patients who suffer kidney damage during surgery die, while others need a lifelong dialysis or kidney transplants. And keeping this in mind researchers at Intermountain Medical Center for the first time have launched a new safety study of an investigational adult stem cell treatment that may repair kidney damage suffered during heart surgery.